Below is a text only representation of the Patient Information Leaflet (ePIL).
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PLGB 27925/0104.
Dexdor 100 micrograms/ml concentrate for solution for infusion
Package leaflet: Information for the user
Dexdor 100 micrograms/ml concentrate for solution for infusion
dexmedetomidine
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or nurse.
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Dexdor is and what it is used for 2. What you need to know before you are given Dexdor 3. How to use Dexdor 4. Possible side effects 5. How to store Dexdor 6. Contents of the pack and other information
1. What Dexdor is and what it is used for
Dexdor contains an active substance called dexmedetomidine which belongs to a medicine group called sedatives. It is used to provide sedation (a state of calm, drowsiness or sleep) for adult patients in hospital intensive care settings or awake sedation during different diagnostic or surgical procedures.
2. What you need to know before you are given Dexdor
You must not be given Dexdor
if you are allergic to dexmedetomidine or any of the other ingredients of this medicine (listed in section 6).
if you have some disorders of heart rhythm (heart block grade 2 or 3).
if you have very low blood pressure which does not respond to treatment.
if you have recently had a stroke or other serious condition affecting blood supply to the brain.
Warnings and precautions
Before you have this medicine, tell your doctor or nurse if any of the following apply as Dexdor should be used cautiously:
if you have an abnormally slow heart rate (either due to illness or high levels of physical fitness) as it may increase the risk for cardiac arrest
if you have low blood pressure
if you have low blood volume, for example after bleeding
if you have certain heart disorders
if you are elderly
if you have a neurological disorder (for instance head or spinal cord injury or stroke)
if you have severe liver problems
if you have ever developed a serious fever after some medicines, especially anaesthetics
This medicine may cause large amount of urine and excessive thirst, contact a doctor if these side effects occur. See section 4 for more information.
Other medicines and Dexdor
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.
The following medicines may enhance the effect of Dexdor:
medicines that help you sleep or cause sedation (e.g. midazolam, propofol)
strong pain medicines (e.g. opioids such as morphine, codeine)
If you are using medicines which lower your blood pressure and heart rate, co-administration with Dexdor may enhance this effect. Dexdor should not be used with medicines that cause temporary paralysis.
Pregnancy and breast-feeding
Dexdor should not be used during pregnancy or breast-feeding unless clearly necessary.
Ask your doctor for advice before having this medicine
Driving and using machines
Dexdor has major impact on the ability to drive and use machines. After you have been given Dexdor you must not drive, operate machinery, or work in dangerous situations until the effects are completely gone. Ask your doctor when you can start doing these activities again and when you can go back to this kind of work.
Excipients
Dexdor contains less than 1 mmol sodium (23 mg) per ml, that is to say essentially ‘sodium-free’.
3. How to use Dexdor
Hospital intensive care
Dexdor is administered to you by a doctor or nurse in hospital intensive care.
Procedural sedation/awake sedation
Dexdor is administered to you by a doctor or a nurse prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.
Your doctor will decide on a suitable dose for you. The amount of Dexdor depends on your age, size, general condition of health, the level of sedation needed and how you respond to the medicine. Your doctor may change your dose if needed and will monitor your heart and blood pressure during the treatment.
Dexdor is diluted and it is given to you as an infusion (drip) into your veins.
After sedation/wake-up
The doctor will keep you under medical supervision for some hours after the sedation to make sure that you feel well.
You should not go home unaccompanied.
Medicines to help you sleep, cause sedation or strong painkillers may not be appropriate for some time after you have been given Dexdor. Talk to your doctor about the use of these medicines and about the use of alcohol.
If you have been given more Dexdor than you should
If you are given too much Dexdor, your blood pressure may go up or down, your heartbeat may slow down, you may breathe more slowly and you may feel more drowsy. Your doctor will know how to treat you based on your condition.
If you have any further questions on the use of this medicine, ask your doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (affects more than 1 user in 10)
slow heart rate
low or high blood pressure
change in breathing pattern or stopping breathing.
Common (affects 1 to 10 users in 100)
chest pain or heart attack
fast heart rate
low or high blood sugar
nausea, vomiting or dry mouth
restlessness
high temperature
symptoms after stopping the medicine.
Uncommon (affects 1 to 10 users in 1,000)
reduced heart function, cardiac arrest
swelling of the stomach
thirst
a condition where there is too much acid in the body
low albumin level in blood
shortness of breath
hallucinations
the medicine is not effective enough.
Not known (frequency cannot be estimated from the available data)
large amount of urine and excessive thirst – may be symptoms of a hormonal disorder called diabetes insipidus. Contact a doctor if these occur.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Dexdor
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP.
This medicine does not require any special temperature storage conditions. Keep the ampoules or vials in the outer carton in order to protect from light.
6. Contents of the pack and other information
What Dexdor contains
The active substance is dexmedetomidine. Each ml of concentrate contains dexmedetomidine hydrochloride equivalent to 100 micrograms dexmedetomidine.
The other ingredients are sodium chloride and water for injections.
Each 2 ml ampoule contains 200 micrograms of dexmedetomidine (as hydrochloride).
Each 2 ml vial contains 200 micrograms of dexmedetomidine (as hydrochloride).
Each 4 ml vial contains 400 micrograms of dexmedetomidine (as hydrochloride).
Each 10 ml vial contains 1000 micrograms of dexmedetomidine (as hydrochloride).
The concentration of the final solution after dilution should be either 4 micrograms/ml or 8 micrograms/ml.
What Dexdor looks like and contents of the pack
Concentrate for solution for infusion (sterile concentrate).
The concentrate is a clear, colourless solution.
Containers
2 ml glass ampoules
2, 5 or 10 ml glass vials
Pack sizes
5 x 2 ml ampoules
25 x 2 ml ampoules
5 x 2 ml vials
4 x 4 ml vials
4 x 10 ml vials
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Orion Corporation Orionintie 1 FI-02200 Espoo Finland
Manufacturer
Orion Corporation Orion Pharma Orionintie 1 FI-02200 Espoo Finland
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
United Kingdom
Orion Pharma (UK) Ltd.
Tel: + 44 1635 520 300
This leaflet was last revised in
July 2022.
Orion Pharma (UK) Limited
Address
Abbey Gardens, 4 Abbey Street, Reading, RG1 3BA, UK